When was Acesion Pharma founded?

Acesion Pharma was founded in 2011 and raised its 1st funding round within a year of its incorporation.

Where is Acesion Pharma located?

Acesion Pharma is headquartered in Copenhagen, Denmark.

Which legal entities is Acesion Pharma associated with?

Acesion Pharma is associated with Acesion Pharma Aps.

How many employees does Acesion Pharma have?

As of Aug 31, 2026, the latest employee count at Acesion Pharma is 22.

Is Acesion Pharma a funded company?

Acesion Pharma is a funded company, having raised a total of $68.4M across 10 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Jan 2011.

When was the latest funding round of Acesion Pharma?

Acesion Pharma's latest funding was a $***** Series B round on Sep 26, 2023, with participation from 4 investors.

What is the annual revenue of Acesion Pharma?

Annual revenue of Acesion Pharma is between undefined and undefined as on Dec 31, 2019

Where does Acesion Pharma rank among its competitors?

Acesion Pharma ranks 1st amongst 5 active competitors, of which 3 are funded. It stands 1st in terms of total funding among its competitors. The most recent competitor to raise funding was Inomagen, which secured $140K in Jun, 2025.

Who are the top competitors of Acesion Pharma?

Acesion Pharma's top competitors include MITEM Pharma, Inomagen and Arvada. Among them, Inomagen secured the most recent funding round in June, 2025.

Acesion Pharma - 2026 Company Profile, Team, Funding, Competitors & Financials

Company Details

Developer of drugs for treating atrial fibrillation. It offers AP30663 first-in-class SK channel inhibitor developed for rapid conversion of atrial fibrillation to normal sinus rhythm through an intravenous infusionand AP31969 for maintenance of sinus rhythm for chronic oral (tablet) treatment.

Website: acesionpharma.com
Social

Key Metrics

Founded Year

2011

Location

Copenhagen, Denmark

Stage

Series B

Total Funding

$68.4M in 10 rounds

Latest Funding Round

Series B, Sep 26, 2023, $*****

Investors

Novo Holdings & 9 more

Ranked

1^st among 5 active competitors

Annual Revenue

as on Dec 31, 2019

Employee Count

22 as on Aug 31, 2026

Investment & Acquisitions

Coinify & 1 more

Similar Companies

MITEM Pharma & 4 more

View Acesion Pharma's full profile

Acesion Pharma is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Acesion Pharma Aps CIN: 34083738 , Denmark, Active	Dec 14, 2011	(As on Dec 31, 2019)	12 (As on Nov 30, 2024)

Acesion Pharma has raised a total funding of $68.4M over 10 rounds. Its first funding round was on Jan 2011. Its latest funding round was a Series B round on Sep 26, 2023 for $*****. 4 investors participated in its latest round. Acesion Pharma has 10 institutional investors.

Here is the list of recent funding rounds of Acesion Pharma:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Sep 26, 2023	9576729	Series B	2314229	6083998	7146695	3504644
Sep 30, 2020	1315410	Series B	7564763	7807879	6487689	8623994
May 03, 2019	1689919	Series B	9780765	2946470	FC Capital	1022146

Access funding benchmarks and valuations. Sign up today!

View details of Acesion Pharma's funding rounds and investors

The founders of Acesion Pharma is Morten Grunnet.

Here are the details of Acesion Pharma's key team members:

Morten Grunnet: Co-Founder & CSO of Acesion Pharma. They serve on the board of 1 company.

Acesion Pharma's Board of Directors

Acesion Pharma's board has 5 active members. Ann Miller, Morten Døssing, Jørgen Søberg Petersen, Torgeir Vaage and Karen Chu are independent board members.

Here is the list of Acesion Pharma's board of directors:

Name	Type	Representing	Status	Duration
ildpdnq	Team	-	Past	8y 9m
ujxzgci	Team	-	Past	1y 8m
Ann Miller	Independent board member	-	Current	7y 10m
{xbgykc	Independent board member	-	Current	7y 2m
ougskjj	Independent board member	-	Current	8y 6m
dgfbzrc	Independent board member	-	Current	4y 2m
drjopgk	Independent board member	-	Current	5y 4m

View details of Acesion Pharma's Founder profiles and Board Members

Acesion Pharma's employee count trend

Acesion Pharma has 22 employees as of Aug 26. Here is Acesion Pharma's employee count trend over the years:

Uncover Acesion Pharma's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Acesion Pharma include MITEM Pharma, Inomagen and Arvada. Here is the list of Top 10 competitors of Acesion Pharma, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Acesion Pharma 2011, Copenhagen (Denmark), Series B	Developer of drugs for treating atrial fibrillation	$68.4M	Canaan, Alpha Wave Global & 8 others	53/100
2nd	MITEM Pharma 2016, Paris (France), Series B	Developer of targeted therapies to treat multiple diseases	$10.8M	TechLife Capital	33/100
3rd	Inomagen 2021, Chicago (United States), Seed	Developer of gene therapy for treating cardiovascular diseases	$340K	NIH SBIR/STTR, HHS	32/100
4th	Arvada 2022, Boston (United States), Unfunded	Developer of therapeutics for cardiac arrhythmias treatment	-	-	30/100
5th	Rhythm Therapeutics 2014, United States, Funding Raised	Developer of medicine for atrial fibrillation	-	Portal Innovations, Government of Canada	29/100
6th	Blue Ash Therapeutics 2008, Cincinnati (United States), Deadpooled	Developer of drug for cardiovascular disorders	$2M	CincyTech, Queen City Angels & 3 others	25/100